Диссертация (1146664), страница 21
Текст из файла (страница 21)
881–888.140. Emilsson V., Liu Y. L., Cawthorne M. A., et al. Expression of the functionalleptin receptor mRNA in pancreatic islets and direct inhibitory action of leptinon insulin secretion // Diabetes. – 1997. – Vol. 46. P. 313–316.130141. Escobar-Morreale H. F., Botella-Carretero J. I., Villuendas G. Seruminterlikin-18 concentrations are increased in the polycystic ovary syndrome:relationship to insulin resistance and to obesity // J.
Clin. Endocrinol. Metab. –2004. – Vol. 89 (2). – P. 806–811.142. Fauvel J. P., Haji-Aissa A., Laville M. et al. Microalbuminuria innormotensive with genetic risk of hypertension // Nephron. – 1991. – Vol. 57.– P. 375–376.143. Fehmann H. C., Bode H. P., Ebert T., et. al. A Interaction of GLP-I and leptinat rat pancreatic B-cells: effects on insulin secretion and signal transduction //Hormone and Metabolic Research.
– 1997. – Vol. 29. P. 572–576.144. Fei H., Okano H. J., Li C. et al. Anatomic localization of alternatively splicedleptin receptors (Ob-R) in mouse brain and other tissues // Proc. Natl. Acad.Sci. USA. – 1997. – Vol. 94. – P. 7001–7005.145. Feldstein C. A., Acopian M., Renauld A. et al.
Insuline resistance andhypertension in postmenopausal women // J. Hum. Hypertens. – 2002. –Vol. 16, Suppl. 1. – P. 145–150.146. Ford E. S. The metabolic syndrome and mortality from cardiovascular diseaseand all-causes: Findings from the National Health and Nutrition ExaminationSurvey II Mortality Study // Atherosclerosis.
– 2004. – Vol. 173. – P. 309–314.147. Frias M. A., Montessuit C. JAK-STAT signaling and myocardial glucosemetabolism // Landes Bioscience. – 2013. – Vol. 2(4) – Р. 26458.148. Fruhbeck G. Pivotal role of nitric oxide in the control of blood pressure afterleptin administration // Diabetes.
– 1999. – Vol. 48. – P. 903–908.149. Fujikawa T., Chuang J. C., Sakata I. et al. Leptin therapy improves insulindeficient type 1 diabetes by CNS-dependent mechanisms in mice // Proc. Natl.Acad. Sci. USA. – 2010. – Vol. 107 (40). – P. 17391-17396.150. Fujioka D., Kawabata K., Saito Y. et al. Role of adiponectin receptors inendothelin-induced cellular hypertrophy in cultured cardiomyocytes and theirexpression in infarcted heart // Am.
J. Physiol. Heart. Circ. Physiol. – 2006. –Vol. 290 – P. 2409–2416.131151. Ganau A. Devereux R. B., Roman M. J. et al. Pattern left ventricularhypertrophy and geometric remodeling in essential hypertension // J. Amer.Coll. Cardiol. – 1992. – Vol. 19. – P. 1550–1558.152. German J. P., Thaler J. P., Wisse B. E. et al. Leptin activates a novel CNSmechanismforinsulin-independentnormalizationofseverediabetichyperglycemia // Endocrinology. – 2011.
– Vol. 152. P. 394–404.153. Gil J. S., Drager L. F., Guerra-Riccio G. M. et al. The impact of metabolicsyndrome on metabolic, proinflammatory and prothrombotic markersaccording to the presence of high blood pressure criterion // Clinics. – 2013. –Vol. 68 (12). – P. 1495–1501.154. Golden S. H., Folsom A. R., Coresh J. et al. Risk factor groupings related toinsulin resistance and their synergistic effects on subclinical atherosclerosis:the Atherosclerosis Risk in Communities (ARIC) study // Diabetes. – 2002. –Vol. 51. – P.
3069–3076.155. Gong W., Yang Z., Ye W. et al. Dysglicemia and cardiovascular disease inpatients with metabolic syndrome // J. Int. Med. Res. - 2009. – Vol. 37 (5). - P.1486-1492.156. Grunfeid В., Perelstein E., Simolo B. et al. Renal function reserve andmicroalbuminuria in offsprings of hypertensive patients // Hypertension. –1990. – Vol. 15. – P.
257–261.157. Gupta J., Mitra N., Kanetsky P. A. et al. Association between albuminuria,kidney function, and inflammatory biomarker profile in CKD in CRIC // Clin.J. Am. Soc. Nephrol. – 2012. – Vol. 7. – P. 1938–1946.158. Guzik T. J., Hoch N. E., Brown K. A. et al. Role of the T cell in the genesis ofangiotensin II–induced hypertension and vascular dysfunctio // The journal ofexperimental medicine.
– 2007. – Vol. 204 (10). – P. 2449–2460.159. Haffner S. M., Katz S. M. Stern M. P., Dunn J.F. Association of decreasedsexhormone-bindingglobulinandcardiovascularArteriosclerosis. – 1989. – Vol. 9 – P. 136–143.132riskfactors//160. Hajamor S., Despres J. P., Couillard C. et al. Relationship beetween sexhormone-binding globulin levels and features of the metabolic syndrome //Metabolism. - 2003.
Vol. 52 (6). - P. 724-730.161. Hall J. E. The kidney, hypertension, and obesity // Hypertension. – 2003.Vol. 41. – P. 625–633.162. Han S. H., Sakuma I., Shin E. K. et al. Antiatherosclerotic and anti-insulinresistance effects of adiponectin: basic and clinical studies // Prog. Cardiovasc.Dis. – 2009. – Vol.
52 (2). – P. 126–140.163. Hashemi M., Kordi-Tamandani D. M. Sharifi N. et al. Serum paraoxonaseand arylesterase activities in metabolic syndrome in Zahedan, southeast Iran //Eur. J. Endocrinol. – 2011. – Vol. 164 (2). – P. 219–222.164. Hernandez-Ono A., Monter-Carreola G., Zamora-Gonzales J. et al.Association of visceral fat with coronary risk factors in population-bassedsample of postmenopausal women // Int. Obes. Relat.
Metab. Disort. – 2001. –Vol. 26. – P. 33–39.165. Higuchi K., Masaki T., Gotoh K. et al. Apelin, an APJ receptor ligand,regulates body adiposity and favors the messenger ribonucleic acid expressionof uncoupling proteins in mice // Endocrinology. – 2007. – Vol. 148. P. 2690–2697.166. Hopkins T. A., Ouchi N., Shibata R., Walsh K. Adiponectin actions in thecardiovascular system // Cardiovascular Research. – 2007. – Vol. 74. – P. 11–18.167. Huo L., Gamber K., Greeley S.
et al. Leptin-dependent control of glucosebalance and locomotor activity by POMC neurons // Cell Metabolism. – 2009.– Vol. 9. – P. 537–547.168. Huot S. J., Aronson P. S. Na+-H+-exchanger and its role in essentialhypertension and diabetes mellitus // Diabetes Care. – 1991. – Vol. 14. –P. 521–535.169. Islam M. S., Sjoholm A., Emilsson V. Fetal pancreatic islets expressfunctional leptin receptors and leptin stimulates proliferation of fetal islet cells133// International Journal of Obesity and Related Metabolic Disorders. – 2000.
–Vol. 24. – P. 1246–1253.170. Ivandic B., Castellani L. W., Wang X. P. et al. Role of group II secretoryphospholipase A(2) in atherosclerosis. Increased atherogenesis and alteredlipoproteins in transgenic mice expressing group IIa phospholipase A(2) //Arterioscler. Thromb. Vasc. Biol.
– 1999. – Vol. 19. – P. 1284–1290.171. Iwasaki Y., Takayasu S., Nishiyama M., et al. Is the metabolic syndrome anintracellular Cushing state? Effects of multiple humoral factors on thetranscriptional activity of the hepatic glucocorticoid-activating enzyme(11beta-hydroxysteroid dehydrogenase type 1) gene // Mol. Cell. Endocrinol. –2008. – Vol. 285 (1-2). – P. 10–18.172. Jassal S. K., Langenberg C., von Muhlen D. et al. Usefulness ofmicroalbuminuria versus the metabolic syndrome as a predictor ofcardiovascular disease in women and men > 40 tears of age (from the RanchoBernardo Study) // Am. J.
Cardiol. – 2008. – Vol. 101. – P. 1275–1280.173. Jia Y. X., Pan C. S., Zhang J., et al. Apelin protects myocardial injury inducedby isoproterenol in rats // Regulatory Peptides. – 2006. Vol. 133. – P. 147–154.174. Julius S., Gudbrandsson T., Jamerson K. et al. The interconnection betweensympathetic microcirculation and insulin resistance in hypertension // BloodPressure. – 1992. – Vol.
1. – P. 9-19.175. Kang Duk-Hee, Park Sung-Kwang, Lee In-Kyu, Johnson R. J. Uric Acid–induced C-reactive protein expression: implication on cell proliferation andnitric oxide production of human vascular cells // J. Am. Soc. Nephrol. – 2005.– Vol. 16. – P. 3553–3562.176. Kawanami D., Maemura K., Takeda N. et al. Direct reciprocal effects ofresistin and adiponectin on vascular endothelial cells: a new insight intoadipocytokine–endothelial cell interactions // Biochem. Biophys. Res.Commun.
– 2004. – Vol. 314. – P. 415–419.134177. Keeley E. C., Mehra B., Janardhanan R. et al. Elevated circulating fibrocytelevels in patients with hypertensive heart disease // Hypertens. – 2012. –Vol. 30 (9). – P. 1856–1861.178. Keller C., Katz R., Cushman M. et al. Association of kidney function withinflammatory and procoagulant markers in a diverse cohort: A cross-sectionalanalysis from the Multi-Ethnic Study of Atherosclerosis (MESA) // BMCNephrology. – 2008.
Vol. 9. Special section p1.179. Kern W. Fittje A., Fohr W. et al. Increase in systolic blood pressure andcatecholamine level during hyperinsulinemia in placebo-controlled euglycemicclamp in heathy subject // Exp. Clin. Endocrinol. Diabetes. – 2000. – Vol.
108.– P. 498–505.180. Kimura K., Tsuda K., Baba A., et al. Involvement of nitric oxide inendothelium dependent arterial relaxation by leptin // Biochem. Biophys. Res.Commun. – 2000. – Vol. 273. – P. 745–749.181. Kieffer T. J., Heller R. S., Leech C. A. et al. Leptin suppression of insulinsecretion by the activation of ATP-sensitive KC channels in pancreatic b-cells// Diabetes.
– 1997. – Vol. 46. – P. 1087–1093.182. Kleinz M. J., Davenport A. P. Immunocytochemical localization of theendogenous vasoactive peptide apelin to human vascular and endocardialendothelial cells // Regulatory Peptides. – 2004. – Vol. 118. – P. 119–125.183. Kleinz M.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
